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The members of the Genomics Workgroup in the Electronic Medical Records and Genomics
(eMERGE) network (Gottesman et al., 2013) led the development of a Special Topic in Frontiers in
Genetics titled “Genetics Research in Electronic Health Records Linked to DNA Biobanks1.” The
goal was to publish papers representing the diverse research ongoing in the integration of elec-
tronic health records (EHR) with genomics through basic, clinical, and translational research. The
special topic with its 18 papers is extremely timely given the recent announcement of the Precision
Medicine initiative by the White House2, which includes the potential to build a biobank of 1 mil-
lion Americans with rich, phenotypic data—likely from EHR. eMERGE has, therefore, served as
an excellent test case for how a 1 million person project might work across several medical centers,
EHR systems, and genetic datasets.
The first group of papers (Almoguera et al., 2014; Crawford et al., 2014; Crosslin et al., 2014;
Verma et al., 2014) belonging to this special issue presents the eMERGE network and its contribu-
tion to genomics. The paper by Crawford et al. (2014) describes the initial goal of eMERGE network
that was to explore the utility of EHRs in genomics and whether the phenotypes identified through
algorithms using EHRs combined with the genome-wide genotypes could lead to fruitful results.
The beginning of the network included individual genotype datasets that were later combined to
form the merged eMERGE datasets and the combination with phenotypes from EHRs has led to
new genomic discoveries. All of these steps subsequently lead to new goals that have included next
generation sequencing and clinical practice. The second paper (Verma et al., 2014) introduces the
new challenges involved in merging genotype data from different eMERGE sites. Since genotypes
at different sites were derived from different genotyping platforms it was impossible to create a
single merged data file based on raw genotype data alone. The solution was first to impute each
site separately using the same software and pipeline, and then merge the imputed genotype data
sets to form a combined dataset. The authors used two different imputation software packages
and describe the challenges involved in using diverse ethnic populations and different genotype
platforms, which lead to a complete pipeline that not only performs imputation but also ensures
appropriate quality control for merging genotype data sets. The final eMERGE imputed data set is
1Available online at: http://journal.frontiersin.org/ResearchTopic/2198
2Available online at: WH.GOV/PRECISION-MEDICINE
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a valuable resource for genomic discovery by using the clini-
cal data generated by the EHRs and will be available in dbGaP
soon. The third paper (Crosslin et al., 2014) discusses the issues
of population stratification and genotype platform bias. Princi-
pal components analysis (PCA) is commonly used to control
for population stratification; however other factors such as local
genomic variation, multiple study sites and multiple genotyp-
ing platforms may also increase the correlation patterns in the
PCA. In this paper Crosslin et al. (2014) provided an alternative
approach to PCA by deriving components from subject loadings
determined by the 1000 Genomes reference sample that avoid
the bias introduced by site and genotype platform effects. This
alternative approach was applied successfully in the eMERGE
genome-wide association study (GWAS) for venous thromboem-
bolism in African Americans. The fourth paper in this group by
Almoguera et al. (2014) evaluated the utility of large imputed
genotype data sets to identify subjects with TPMT defective alle-
les. They used around 87,000 samples from the biobank at the
Children’s Hospital of Philadelphia. For 12 samples also Sanger
sequencing data were available allowing comparison between the
imputed and observed genotypes. The concordance rate between
the non-carriers of the risk alleles was 98.88%; however the sen-
sitivity of imputation for homozygous carriers was ∼80%. The
authors recommend using imputation of TMPT alleles as a first
step to screen individuals at risk.
The papers of group 2 (Kullo et al., 2014a; Mitchell et al.,
2014; Namjou et al., 2013; Parihar et al., 2014; Ye et al., 2014)
describe different applications of the EHR derived phenotypes.
The first paper (Namjou et al., 2013) investigated whether the
common variants in the genes FTO, MC4R and TMEM18 asso-
ciated with BMI in adults are also associated in pediatric popula-
tion in the eMERGE network. First they used a linear regression
model with the dependent variable BMI, adjusted for age, sex,
and PC by cohort; and then meta-analyzed the results using a
weighted z-score approach. They not only reproduced the find-
ings for the pediatric cohorts but also identified a novel locus at
COL6A5. The second paper (Mitchell et al., 2014) described the
issues when using cases generated from Stroke Genetics Network
(SiGN) and using genotyped controls from eMERGE leading
to recommendations regarding the controls selection, popula-
tion stratification, imputation, and association analysis. The third
paper by Kullo et al. (2014a) performed a two-stage association
study to identify variants associated with peripheral arterial dis-
ease. The first stage was a GWAS adjusted for age and sex in
subjects of European ancestry. In the second stage the top 48
SNPs were replicated in new set of cases and controls. One sin-
gle nucleotide polymorphism (SNP) in the ATXN2-SH2B3 gene
was significant where this SNP is in high LD with a missense
variant in SH2B3, a gene that is related to immune and inflam-
matory response pathways and vascular homeostasis, indicat-
ing a pleiotropic effect. The fourth paper (Parihar et al., 2014)
carried out a GWAS for lipid-related phenotypes derived from
the EHR using the Metabochip array. These phenotypes con-
sist of laboratory, anthropomorphic and demographic data on a
cohort of extremely obese subjects. They replicated 12 of 21 pre-
viously identified lipid-associated SNPs demonstrating the valid-
ity of using phenotype data available from the EHR and the
usefulness of the Metabochip array. The fifth paper (Ye et al.,
2014) performed GWAS to identify genetic variants associated
with diseases caused by Staphylococcus aureus infection. They
used different approaches to identify the genetic susceptibility
from single SNP, gene set and pathway. No SNPs or genes were
found to be genome-wide significant leaving with the speculation
that multiple genes contribute to the severity of the infection.
The third group of papers (Connolly et al., 2014; Cronin et al.,
2014; Namjou et al., 2014; Patel et al., 2014; Sun et al., 2014) in this
special issue focused on more complex analyses of the genome
including copy number variants (CNV), pleiotropy combined
with phenome-wide association studies (PheWAS), and epista-
sis (gene-gene interactions). The first paper by Namjou et al.
(2014) describes the first PheWAS in a pediatric cohort based on
4268 samples and 2476 sSNPs selected from previously published
GWAS studies. A total of 539 EMR-derived phenotypes were
explored. The authors identified a number of known associations
which serve as a positive control as well as several novel associ-
ations including NDFIP1 associated with mental retardation and
PLCL1 associated with developmental delays and speech disor-
der. The second paper by Cronin et al. (2014) is another Phe-
WAS, focused on one specific gene, FTO, in 10,487 individuals
from the eMERGE network and another 13,711 individuals from
the Vanderbilt biobank BioVU. They identified highly significant
associations between FTO and obesity, type II diabetes, and sleep
apnea, all of which are expected for variants in this gene. A novel
association was identified between FTO and fibrocystic breast
disease. The third paper by Sun et al. (2014) is a review of meth-
ods to filter genome-wide SNP data to explore epistasis models
effectively. There are a number of challenges with the search for
epistasis in genome-wide data including the computational com-
plexity of exploring that many different combinations of variables
which can exceed computational feasibility as well as the mag-
nitude of the multiple testing incurred by testing the genome in
exhaustive interaction analyses. The authors discuss two different
filtering approaches, namely using statistical effects or biologi-
cal prior knowledge. Strengths and weakness of these different
strategies are described as well as additional resources for con-
sideration before a genome-wide epistasis analysis is initiated.
The fourth paper by Connolly et al. (2014) is a review on recent
research in the area of CNV including successful applications in
rare and common diseases. Methods for identifying CNVs from
array-based genotyping data and sequencing data are described.
Finally, how CNVs might be evaluated and used with medical
records is discussed. The fifth paper of this group is by Patel et al.
(2014) and describes quality control processes for whole exome
sequencing data, specifically using Mendelian errors as a filtering
strategy to minimize errors. The group developed the Cincin-
nati Analytical Suite for Sequencing Informatics (CASSI) to store
sequencing files, metadata, and others. Their data cleaning pro-
cess can be used to improve the signal-to-noise ratio and improve
the identification of candidate disease causative variants.
The fourth group of papers (Goldstein et al., 2014; Kullo et al.,
2014b; Schrodi et al., 2014; Sleiman et al., 2014) belonging to this
special issue discusses the use of genetic data together with EHR-
derived clinical data in clinical settings. The first one of these
papers (Sleiman et al., 2014) used imputed GWAS data to study
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two loss-of-function variants in the PCSK9 gene. The study of
8028 genotyped biobank participants with extensive laboratory
data from the EHR demonstrated that EHR-linked biobanks are
a rich resource for exploring functional aspects of genetic vari-
ants. The second paper (Schrodi et al., 2014) is a review article
about genetic-based prediction by Schrodi et al. (2014) and it
provides a comprehensive discussion about disease prediction
using both genetic and clinical data, again highlighting the use-
fulness of available EHR-linked genetic data on large cohorts.
As the title of their article reveals, predicting who is at risk for
a given disease has turned out to be a difficult task. Currently
the most promising results can be found in cancer genomics,
population screening of rare Mendelian diseases, and pharma-
cogenetics. Developing prediction models for common complex
diseases such as type 2 diabetes mellitus, stroke and inflamma-
tory arthritis has beenmore challenging and the results have been
disappointing. This was also evident in the third paper of this
group (Goldstein et al., 2014) in which coronary heart disease was
investigated in the NIH-funded Atherosclerosis Risk in Commu-
nities (ARIC) cohort. The authors combined a genetic risk score
derived from 45 SNPs with a clinical risk score, but received only
minimal improvement in discrimination and calibration statis-
tics of the risk score. Schrodi et al. (2014) conclude their review
article with a positive note pointing out that in the near future we
can rely on having access to additional genome-wide data which
might help in refining the risk prediction. These data will include
whole genome and whole exome sequence data, and other omics
data such as information on DNA methylation, histone modi-
fication, and the transcriptomes of different tissues. Additional
advances leading to more refined phenotyping, and development
of new, more robust computational approaches will contribute
to improved accuracy in risk estimates. The last paper in the
fourth group (Kullo et al., 2014b) deals with the key questions
about returning results to patients and providers. The authors are
from the eMERGE network and point out that one of the man-
dates of the network is to come up with the best practices for
implementing genomic medicine. The goal is to have the clini-
cally relevant genetic results in the EHR so that they are easily
available for the practicing physician to be used at point-of-care.
These results could be individual risk genotypes or combined
risk scores. Each of the eMERGE network sites is carrying out
a feasibility projects, e.g., the group at Icahn School of Medicine
at Mount Sinai is using APOL1 variants in African Americans
to predict chronic kidney disease and investigators at Vanderbilt
University have chosen 14 actionable pharmacogenetic variants
to be returned to the EHR.
Precision medicine (See Footnote 2) is an important focus
for biomedical, clinical and translational informatics in the cur-
rent era. The manuscripts presented in this special topic are
well positioned to educate and demonstrate the potential study
designs, methods, strategies, and applications where this type of
research can be performed successfully. The ultimate goal is to
improve diagnostics and provide better, more targeted care to the
patient.
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